CHRISTINA MILLER: Open Payments
NPI 1427497890 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 34 payments from 12 companies in 2025. Trend: 2023 $667 · 2024 $1,155 · 2025 $820
Food & beverage: $820
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 5 | $209 |
| Boston Scientific Corporation | 2 | $100 |
| PFIZER INC. | 4 | $91 |
| Novartis Pharmaceuticals Corporation | 5 | $85 |
| Merck Sharp & Dohme LLC | 4 | $74 |
| SCPHARMACEUTICALS INC. | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| Chiesi USA, Inc. | 2 | $35 |
| ABIOMED | 2 | $33 |
| Actelion Pharmaceuticals US, Inc. | 1 | $32 |
Products named: AMVUTTRA, WATCHMAN FLX, ONPATTRO, LEQVIO, VYNDAQEL, FUROSCIX, VERQUVO, ELIQUIS.
Industry payments across OH — which companies pay providers there.
